Research Story Tip: Grants, Management Roles Keep Johns Hopkins A Leader In Hiv/Aids Clinical Trial

Date: 12/08/2020

Publication:

hopkinsmedicine.org

This World AIDS Day, HIV/AIDS researchers at Johns Hopkins Medicine learned that they now have an enhanced opportunity to help move the world toward a day when that observance is rendered obsolete. The National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases (NIAID) announced Dec. 1, 2020, that Johns Hopkins Medicine will receive five of the seven-year grants awarded to 35 U.S. and international institutions to operate clinical trial units (CTUs) and coordinate HIV/AIDS clinical trials in four federally funded networks.

The three CTU grants and two leadership awards for Johns Hopkins Medicine are the most given to any one institution.

Full Article Here

Clinical Trials

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5350: Effects of Visbiome Extra Strength on Gut Microbiome...

Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...

Read More

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More